[LGND] QoQ Quarter Result on 30-Jun-2013 [#Q2]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
01-Aug-2013
Financial Year
2013
Quarter
30-Jun-2013 [#Q2]
Profit Trend
QoQ- 307.42%
YoY- 368.68%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
Revenue 15,958 14,737 13,005 9,580 11,651 13,635 6,375 84.46%
PBT 2,150 2,008 2,025 3,804 1,370 950 -52 -
Tax 53 139 60 110 66 -1,636 142 -48.19%
NP 2,097 1,869 1,965 6,091 1,495 1,063 -194 -
Tax Rate -2.47% -6.92% -2.96% -2.89% -4.82% 172.21% - -
Total Cost 13,861 12,868 11,040 3,489 10,156 12,572 6,569 64.58%
Ratio Analysis
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
NP Margin 13.14 12.68 15.11 63.58 12.83 7.80 -3.04 -
Per Share
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
EPS 0.10 0.09 0.10 0.30 0.07 0.05 -0.01 -
EPS Diluted 0.10 0.09 0.09 0.30 0.07 0.05 -0.01 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.